Biotech company PharmAust Limited is pleased to announce a significant milestone for a four-legged patient in the Phase 2 trial for the treatment of canine B-cell Lymphoma. Thirteen-year-old Beagle ‘Louie’ from New Zealand has surpassed 365 days (one year) as a result...

read more